Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension

References

• MathersCDLoncarDProjects of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
   PubMed Web of Science ®Google Scholar
• EzzatiMEstimates of global and regional potential health gains from reducing multiple major risk factorsLancet2003362938027128012892956
   PubMed Web of Science ®Google Scholar
• PetersenSPetoVRaynerMEuropean Cardiovascular Disease StatisticsLondon, UKBritish Heart Foundation2005
   Google Scholar
• LealJLuengo-FernándezRGrayAEconomic burden of cardiovascular diseases in the enlarged European UnionEur Heart J200627131610161916495286
   PubMed Web of Science ®Google Scholar
• LawesCMVander HoomSRodgersAInternational Society of Hypertension. Global burden of blood pressure-related disease, 2001Lancet200837196231513151818456100
   PubMed Web of Science ®Google Scholar
• LopezADMathersCDEzzatiMGlobal and regional burden of disease and risk factors, 2001: systematic analysis of population health dataLancet200636795241747175716731270
   PubMed Web of Science ®Google Scholar
• LewingtonSClarkeRQizilbashNProspective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet200236093491903191312493255
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGDominiczakA2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20072561105118717563527
   PubMed Web of Science ®Google Scholar
• StegPGBhattDLWilsonPWOne-year cardiovascular event rates in outpatients with atherothrombosisJAMA2007297111197120617374814
   PubMed Web of Science ®Google Scholar
• CapewellSMurphyNFMacIntyreKShort-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990–2000: population-based cohort studyHeart200692111563157016775090
   PubMed Web of Science ®Google Scholar
• DhamoonMSSciaccaRRRundekTRecurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan StudyNeurology200666564164616534100
   PubMed Web of Science ®Google Scholar
• Cea-CalvoLConthePGómez-Fernández-PérezCRICARHD InvestigatorsTarget organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional studyCardiovasc Diabetol200652317083718
   PubMed Web of Science ®Google Scholar
• YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet2004364943893795215364185
   PubMed Web of Science ®Google Scholar
• DzauVBraunwaldEResolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statementAm Heart J19911214 Pt 1124412632008853
   PubMed Web of Science ®Google Scholar
• DzauVJAntmanEMBlackHRThe cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)Circulation2006114252850287017179034
   PubMed Web of Science ®Google Scholar
• BakrisGBöhmMDagenaisGCardiovascular protection for all individuals at high risk: evidence-based best practiceClin Res Cardiol2008971071372518726243
   PubMed Web of Science ®Google Scholar
• Cholesterol Treatment Trialists’ (CTT) CollaborationEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statinsLancet200536694931267127816214597
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patientsBMJ20023247329718811786451
   PubMed Web of Science ®Google Scholar
• DuckworthWAbrairaCMoritzTGlucose control and vascular complications in veterans with type 2 diabetesN Engl J Med2009360212913919092145
   PubMed Web of Science ®Google Scholar
• StaessenJALiYThijsLWangJGBlood pressure reduction and cardiovascular prevention: an update including the 2003–2004 secondary prevention trialsHypertens Res200528538540716156503
   PubMed Web of Science ®Google Scholar
• The ACCORD Study GroupEffects of intensive blood-pressure control in type 2 diabetes mellitusN Engl J Med2010362171575158520228401
   PubMed Web of Science ®Google Scholar
• AppelLJWrightJTJrGreeneTAASK Collaborative Research GroupIntensive blood-pressure control in hypertensive chronic kidney diseaseN Engl J Med20103631091892920818902
   PubMed Web of Science ®Google Scholar
• ManciaGLaurentSAgabiti-RoseiEEuropean Society of HypertensionReappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documentJ Hypertens200927112121215819838131
   PubMed Web of Science ®Google Scholar
• Wolf-MaierKCooperRSKramerHHypertension treatment and control in five European countries, Canada, and the United StatesHypertension2004431101714638619
   PubMed Web of Science ®Google Scholar
• WongNDLopezVAL’ItalienGInadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003–2004Arch Intern Med2007167222431243618071164
   PubMedGoogle Scholar
• Mustone AlexanderLDesirable therapeutic characteristics of an optimal antihypertensive agentDrugs20066691239125216827600
   PubMed Web of Science ®Google Scholar
• MulcahyDCircadian variation in cardiovascular eventsBlood Press Monit199831293410212329
   PubMedGoogle Scholar
• SchmiederREHilgersKFSchlaichMPSchmidtBMRenin-angiotensin system and cardiovascular riskLancet200736995681208121917416265
   PubMed Web of Science ®Google Scholar
• WangYRAlexanderGCStaffordRSOutpatient hypertension treatment, treatment intensification, and control in Western Europe and the United StatesArch Intern Med2007167214114717242314
   PubMedGoogle Scholar
• TedescoMANataleFCalabroREffects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patientsJ Clin Hypertens200689634641
   PubMedGoogle Scholar
• WeirMRTargeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockadeJ Hum Hypertens2007211077077917597800
   PubMed Web of Science ®Google Scholar
• EganBMCombination therapy with an angiotensin converting enzyme inhibitor and a calcium channel blockerJ Clin Hypertens2007910783789
   Google Scholar
• EpsteinMBakrisGNewer approaches to antihypertensive therapy. Use of fixed-dose combination therapyArch Intern Med199615617196919788823150
   PubMedGoogle Scholar
• WeberMABakrisGLDahlofBBaseline characteristics in the Avoiding Cardiovascular Events Through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular riskBlood Press2007161131917453747
   PubMed Web of Science ®Google Scholar
• DahlofBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding per-indopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet2005366948989590616154016
   PubMed Web of Science ®Google Scholar
• KjeldsenSEJamersonKABakrisGLPredictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH studyBlood Press200817171718568687
   PubMed Web of Science ®Google Scholar
• AllemannYFraileBLambertMEfficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure After Single Therapy (EX-FAST) studyJ Clin Hypertens2008103185194
   PubMed Web of Science ®Google Scholar
• ChrysantSGMelinoMKarkiSThe combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety studyClin Ther200830458760418498909
   PubMed Web of Science ®Google Scholar
• ONTARGET InvestigatorsYusufSTeoKKPogueJTelmisartan, ramipril, or both in patients at high risk for vascular eventsN Engl J Med2008358151547155918378520
   PubMed Web of Science ®Google Scholar
• LittlejohnTW3rdMajulCROlveraRResults of treatment with telmisartan-amlodipine in hypertensive patientsJ Clin Hypertens (Greenwich)200911420721319614805
   PubMed Web of Science ®Google Scholar
• LittlejohnTW3rdMajulCROlveraRTelmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 × 4 factorial studyPostgrad Med2009121251419332958
   PubMed Web of Science ®Google Scholar
• WhiteWBLittlejohnTWMajulCREffects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1–2 hypertensionBlood Press Monitor2010154205212
   PubMed Web of Science ®Google Scholar
• FogariRDerosaGZoppiAEffect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuriaAm J Hypertens200720441742217386350
   PubMed Web of Science ®Google Scholar
• MurphyJCosterGIssues in patient complianceDrugs19975467978009421690
   PubMed Web of Science ®Google Scholar
• MichalsenAKonigGThimmeWPreventable causative factors leading to hospital admission with decompensated heart failureHeart19988054374419930040
   PubMed Web of Science ®Google Scholar
• GehiAKAliSNaBSelf-reported medication adherence and CV events in patients with stable coronary heart disease: the heart and soul studyArch Inter Med20071671617981803
   PubMedGoogle Scholar
• SokolMCMcGuiganKAVerbruggeRRImpact of medication adherence on hospitalization risk and healthcare costMed Care200543651752015908845
   PubMed Web of Science ®Google Scholar
• EspostiLDDi MartinoMSaragoniSPharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapiesJ Clin Hypertens2004627684
   Google Scholar
• CorraoGZambonAParodiADiscontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in ItalyJ Hypertens200826481982418327094
   PubMed Web of Science ®Google Scholar
• DeziiCMMedication noncompliance: what is the problem?Manag Care200099 Suppl71211729418
   PubMedGoogle Scholar
• ClaxtonAJCramerJAPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
   PubMed Web of Science ®Google Scholar
• SicaDSingle pill combination antihypertensive drugs. Do they have a role in rational therapy?Drugs199448116247525192
   PubMed Web of Science ®Google Scholar
• BramleyTJGerbinoPPNightengaleBSFrech-TamasFRelationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizationsJ Manag Care Pharm200612323924516623608
   PubMed Web of Science ®Google Scholar
• BangaloreSKamalakkannanGParkarSFixed-dose combinations improve medication compliance: a meta-analysisAm J Med2007120871371917679131
   PubMed Web of Science ®Google Scholar
• GuptaAKArshadSPoulterNRCompliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysisHypertension201055239940720026768
   PubMed Web of Science ®Google Scholar